Related Experiment Video
Updated: Aug 18, 2026

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease
Andrew W Michell1, Leila M Luheshi, Roger A Barker
1Cambridge Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge CB22PY, UK. awm13@cam.ac.uk
Abstract:
Parkinson's disease (PD) is a heterogeneous disease that can be difficult to diagnose, and for which we have no simple effective biomarker. In this study we have investigated whether peripheral alpha-synuclein might represent a useful biomarker given that it has a central role in the pathogenesis of PD. We found that full length and truncated alpha-synuclein is present in platelets, but the amount is very variable and does not correlate with disease presence or severity. Furthermore, we show that alpha-synuclein can be detected by immunoblotting in some, but not all, human skin biopsies, but again its level does not correlate with disease presence or severity. We conclude that skin or platelet alpha-synuclein would not be an appropriate diagnostic biomarker for PD.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Alterations in Muscle Tone lll

